154 related articles for article (PubMed ID: 8757530)
1. Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous factor XI deficiency.
Castaman G; Ruggeri M; Rodeghiero F
Br J Haematol; 1996 Jul; 94(1):168-70. PubMed ID: 8757530
[TBL] [Abstract][Full Text] [Related]
2. [Familial study of factor XI deficiency. Presurgical prophylactic treatment with desmopressin plus antifibrinolytics].
García Fernández JR; Sánchez Forte M; Diego Fernández Pd; López Berenguel F; Moreno Madrid F
An Esp Pediatr; 2002 Oct; 57(4):373-7. PubMed ID: 12392675
[TBL] [Abstract][Full Text] [Related]
3. The use of desmopressin in congenital factor XI deficiency: a systematic review.
Franchini M; Manzato F; Salvagno GL; Montagnana M; Lippi G
Ann Hematol; 2009 Oct; 88(10):931-5. PubMed ID: 19609524
[TBL] [Abstract][Full Text] [Related]
4. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
O'Connell NM; Riddell AF; Pascoe G; Perry DJ; Lee CA
Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352
[TBL] [Abstract][Full Text] [Related]
6. New observations on factor XI deficiency.
Salomon O; Seligsohn U
Haemophilia; 2004 Oct; 10 Suppl 4():184-7. PubMed ID: 15479396
[TBL] [Abstract][Full Text] [Related]
7. [Factor XI deficiency: do patients with hemorrhagic diathesis also have hemostasis defects?].
Peter MK; Meili EO; von Felten A
Schweiz Med Wochenschr; 1996 Jun; 126(23):999-1005. PubMed ID: 8701241
[TBL] [Abstract][Full Text] [Related]
8. Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study.
Bauduer F; de Raucourt E; Boyer-Neumann C; Trossaert M; Beurrier P; Faradji A; Peynet J; Borg JY; Chamouni P; Chatelanaz C; Henriet C; Bridey F; Goudemand J;
Haemophilia; 2015 Jul; 21(4):481-9. PubMed ID: 25817556
[TBL] [Abstract][Full Text] [Related]
9. Report of surgeries, their outcome and the thrombin generation assay in patients with Factor XI deficiency: A retrospective single-centre study.
Désage S; Dargaud Y; Meunier S; Le Quellec S; Lienhart A; Negrier C; Nougier C; Rugeri L
Haemophilia; 2022 Mar; 28(2):301-307. PubMed ID: 35122661
[TBL] [Abstract][Full Text] [Related]
10. [Postoperative haemorrhagia in a girl with congenital factor XI deficiency - successful treatment with desmopressin (DDAVP, Minirin(R))].
Heim MU; Lutze G; Aumann V; Schumacher J; Freigang B
Klin Padiatr; 2002; 214(3):128-31. PubMed ID: 12015646
[TBL] [Abstract][Full Text] [Related]
11. Use of desmopressin for prophylaxis of surgical bleeding in factor XI-deficient patients.
Bauduer F; Bendriss P; Freyburger G; Ducout L; Marti B
Acta Haematol; 1998; 99(1):52-3. PubMed ID: 9490569
[No Abstract] [Full Text] [Related]
12. Factor XI deficiency in humans.
Seligsohn U
J Thromb Haemost; 2009 Jul; 7 Suppl 1():84-7. PubMed ID: 19630775
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors to Factor XI in patients with severe Factor XI deficiency.
Salomon O; Zivelin A; Livnat T; Seligsohn U
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S10-2. PubMed ID: 16427373
[TBL] [Abstract][Full Text] [Related]
14. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
Santoro C; Di Mauro R; Baldacci E; De Angelis F; Abbruzzese R; Barone F; Bochicchio RA; Ferrara G; Guarini A; Foà R; Mazzucconi MG
Haemophilia; 2015 Jul; 21(4):496-501. PubMed ID: 25623511
[TBL] [Abstract][Full Text] [Related]
15. Management of gynecologic surgery in the patient with factor XI deficiency: a review of the literature.
Steward RG; Saleh OA; James AH; Shah AA; Price TM
Obstet Gynecol Surv; 2012 May; 67(5):291-7. PubMed ID: 22624777
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
[TBL] [Abstract][Full Text] [Related]
17. Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.
Gidley GN; Holle LA; Burthem J; Bolton-Maggs PHB; Lin FC; Wolberg AS
Blood Adv; 2018 May; 2(10):1076-1088. PubMed ID: 29760205
[TBL] [Abstract][Full Text] [Related]
18. Factor XI Deficiency.
Duga S; Salomon O
Semin Thromb Hemost; 2009 Jun; 35(4):416-25. PubMed ID: 19598070
[TBL] [Abstract][Full Text] [Related]
19. Cataract extraction without prophylactic treatment in patients with severe factor XI deficiency.
Fabian ID; Sachs D; Moisseiev J; Alhalel A; Grinbaum A; Seligsohn U; Salomon O
Am J Ophthalmol; 2009 Dec; 148(6):920-4.e1. PubMed ID: 19733832
[TBL] [Abstract][Full Text] [Related]
20. A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency.
Bozzao C; Rimoldi V; Asselta R; Landau M; Ghiotto R; Tenchini ML; De Cristofaro R; Castaman G; Duga S
FEBS J; 2007 Dec; 274(23):6128-38. PubMed ID: 17971173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]